Case Report: Circulating tumor DNA-confirmed complete response in a marker-negative primary mediastinal seminoma with a rare KIT D820V mutation

KIT is the most frequently mutated oncogene in seminoma, and the mutational spectrum in mediastinal seminomas differs from testicular cases. AKT1 point mutations, common in breast, gynecological, and colorectal cancers, are unreported in germ cell tumors. We describe a 52-year-old male with a 12.38 cm anterior mediastinal seminoma (OCT3/4+, CD117+) harboring a pathogenic KIT p.D820V activation loop mutation and a co-occurring AKT1 p.W80R pleckstrin homology variant, representing dual-level PI3K/AKT pathway activation not previously described in a germ cell tumor. Complete response after BEP chemotherapy was confirmed by PET-CT and clearance of circulating tumor DNA (1335.6 to undetectable mean tumor molecules/mL), confirming molecular response in a marker-negative (AFP/β-hCG) extragonadal seminoma. Structural modeling predicts p.D820V confers constitutive kinase activation with sensitivity to type I tyrosine kinase inhibitors. The co-occurrence of upstream KIT and downstream AKT1 mutations has implications for targeted therapy at relapse.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-11-12
DOI
https://doi.org/10.3389/fonc.2026.1955115
Primary Topic
Testicular diseases and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Circulating tumor DNA-confirmed complete response in a marker-negative primary mediastinal seminoma with a rare KIT D820V mutation

Osman Hashmi, Furhan Yunus, Peter Bela Illei, Liban Abdikarim
Frontiers in Oncology
Testicular diseases and treatments
article

Case Report: Circulating tumor DNA-confirmed complete response in a marker-negative primary mediastinal seminoma with a rare KIT D820V mutation

Osman Hashmi, Furhan Yunus, Peter Bela Illei, Liban Abdikarim
article en

Abstract

KIT is the most frequently mutated oncogene in seminoma, and the mutational spectrum in mediastinal seminomas differs from testicular cases. AKT1 point mutations, common in breast, gynecological, and colorectal cancers, are unreported in germ cell tumors. We describe a 52-year-old male with a 12.38 cm anterior mediastinal seminoma (OCT3/4+, CD117+) harboring a pathogenic KIT p.D820V activation loop mutation and a co-occurring AKT1 p.W80R pleckstrin homology variant, representing dual-level PI3K/AKT pathway activation not previously described in a germ cell tumor. Complete response after BEP chemotherapy was confirmed by PET-CT and clearance of circulating tumor DNA (1335.6 to undetectable mean tumor molecules/mL), confirming molecular response in a marker-negative (AFP/β-hCG) extragonadal seminoma. Structural modeling predicts p.D820V confers constitutive kinase activation with sensitivity to type I tyrosine kinase inhibitors. The co-occurrence of upstream KIT and downstream AKT1 mutations has implications for targeted therapy at relapse.

Frontiers in OncologyVol. 16
Johns Hopkins University (US), Johns Hopkins Medicine (US), Mobile Infirmary (US)
Good health and well-being
Testicular diseases and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon